Join the Dialogue on Patient Involvement in Drug Coverage Reviews
June 22, 2011
Join us for a discussion on how patient groups can meaningfully contribute to the drug coverage review process. Hear from Canadian organizations and publicly funded drug plans that have recently implemented a patient input process, and from patient groups who have provided evidence to date. Share with us what would help your group file submissions that provide maximum value to the review process.
- What: Interactive workshop for patient groups
- When: Wednesday, June 22, 2011
- Time: 11:00 a.m. until 4:30 p.m. Lunch provided. Doors open at 10:30 a.m.
- Where: Hilton Toronto, 145 Richmond Street West, Toronto, ON M5H 2L2 (TTC Osgoode)
- How: Email events@CADTH.ca requesting a registration form
- Cost: There is no fee for patient groups and the public health sector. Private sector representatives are welcome to observe and a $200 registration fee will apply.
Our goals for the day:
- increase awareness of how decisions are made in Canada about publicly funded drug coverage and the roles of the different organizations involved in the process
- explain how patient input is integrated into the drug review processes
- provide an overview of the patient input process at the Canadian Agency for Drugs and Technologies in Health (CADTH), Ontario Public Drug Programs, British Columbia Pharmaceutical Services, and the pan-Canadian Oncology Drug Review
- share experiences to date and ideas for preparing patient group submissions that provide added value to the drug reviews and drug coverage decisions.
Hosted by CADTH